Research and Markets: IMS Country Review: Germany (Including Sell-out Data) is Analysed in Terms of Major Corporations, Therapeutic Classes, Major Products and New Product Activity

DUBLIN, Nov 12, 2010 (BUSINESS WIRE) -- Research and Markets ( has announced the addition of the "IMS Country Review: Germany (including sell-out data)" report to their offering.

The IMS Country Reviews provides comprehensive qualitative insights into a specific pharmaceutical market as well as showing sales trends over the last 5 years. Sales performance is analysed in terms of major corporations, therapeutic classes, major products and new product activity.

Key Topics Covered: Section 1: Synopsis of the Healthcare Market Market Trends Healthcare Provision Prescribing Policy Pricing System Regulatory Environment Industry Environment Channels of Distribution Section 2: Country Sales Performance and Trends Figure 1: Country Ranking Amongst 40 Markets Figure 2: Audited Market Trend Figure 3: Leading 35 Local Companies Figure 4: Leading 35 Corporations Figure 5: Market Share By Corporate Nationality Figure 6: Leading 15 Therapeutic Classes (Level 3) Figure 7: 15 Fastest-Growing Therapeutic Classes (Level 3) 2008 Figure 8-22: Leading 15 Therapeutic Class Profiles Figure 23: Leading 40 Products Figure 24: Leading 40 New Products Figure 25: Leading 15 Product Forms Appendices: Appendix 1: Data Values and Definitions Appendix 2: Audited Universe Appendix 3: -Latest Factors Appendix 4: List of USD Exchange Rates 2008 Appendix 5: Country Abbreviations Appendix 6: Anatomical Therapeutic Classification For more information visit Source: IMS Health SOURCE: Research and Markets CONTACT: Research and Markets Laura Wood, Senior Manager, U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Copyright Business Wire 2010 -0- KEYWORD: Germany

Europe INDUSTRY KEYWORD: Professional Services